Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMC

T cell cholesterol transport links intestinal immune responses to dietary lipid absorption

Gao Y., Kennelly JP., Xiao X., Whang E., Ferrari A., Bedard AH.

Animal Study on Systemic / IV, published in Science (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Science (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41066556
PMCID
PMC13034976
DOI
10.1126/science.adt4169
Citations
8

Abstract (original English)

The intrinsic pathways that control membrane organization in immune cells and their impact on cellular functions are poorly defined. We found that the nonvesicular cholesterol transporter Aster-A linked plasma membrane (PM) cholesterol availability in CD4 T cells to systemic metabolism. Aster-A was recruited to the PM during T cell receptor (TCR) activation, where it facilitated the removal of accessible cholesterol. Loss of Aster-A increased cholesterol accumulation in the PM, which enhanced TCR nanoclustering and signaling. Aster-A associated with stromal interaction molecule 1 (STIM1) and negatively regulated calcium (Ca 2+ ) flux. Aster-A deficiency promoted CD4 T cells to acquire a T helper 17 (T H 17) phenotype and stimulated interleukin-22 production, which reduced intestinal fat absorption and conferred resistance to diet-induced obesity. These findings delineate how immune cell membrane homeostasis links to systemic physiology.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
IntestinesIntestinal MucosaCD4-Positive T-LymphocytesCell MembraneAnimalsMice, Inbred C57BLMiceObesityCalciumCholesterol

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research